TERN
TERN
NASDAQ · Pharmaceuticals

Terns Pharmaceuticals Inc

$52.95
+0.00 (+0.00%)
As of Nov 7, 1:31 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target -29.8% upside
Low Target $32.00
Average Target $37.17
High Target $56.15
Current Price $52.95
Current
$52.95
Target
$37.17
$32.00 $37.17 avg $56.15
Scenario Analysis
Bear Case
$32.00
-39.6%
Low target
Base Case
$37.17
-29.8%
Avg target
Bull Case
$56.15
+6.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$53.19
-0.5% from high
52-Week Low
$12.77
+314.6% from low
50-Day SMA
$50.16
+5.6% vs SMA
200-Day SMA
$28.69
+84.6% vs SMA
RSI (14)
81.8
Overbought
Target vs 52W High
$37.17
-30.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%